(BPT) - For years, routine screening recommendations have been limited to four cancers — breast, cervical, colorectal, and high-risk lung cancer — leaving nearly 70% of annual cancer cases and deaths ...

Exact Sciences has launched its long-awaited blood test designed to detect the early stages of multiple tumors, with a plan to sell it to consumers through a telehealth program in a bid to increase ...

Exact Sciences, the makers of the Cologuard ® test, introduced the Cancerguard test which can detect over 50 cancer types and subtypes, including the 6 most deadly forms. 3,4 In addition to analyzing ...

Cancerguard detects multiple cancers early by identifying specific DNA and protein markers in a blood sample. The test is available for adults aged 50-84 without cancer in the past three years, but it ...

Data show how a multi-biomarker class approach improves early-stage cancer detection AACR will also recognize landmark DETECT-A study publication reporting long-term outcomes supporting the clinical ...

Don't miss the big stories. Like us on Facebook. (BPT) - For years, routine screening recommendations have been limited to four cancers — breast, cervical, colorectal, and high-risk lung cancer — ...

Exact Sciences Corporation EXAS has launched the Cancerguard test, a new multi-cancer early detection (MCED) blood test now offered as a laboratory-developed test (LDT) in the United States.